Solitomab, an EpCAM/CD3 bispecific antibody construct (BiTE®), is highly active against primary uterine and ovarian carcinosarcoma cell lines in vitro

Blinatumomab: First Global Approval

(2015) Mark Sanford   DRUGS

Blinatumomab for the treatment of B-cell lymphoma

(2015) Eunhye Oak et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Solitomab, an epithelial cell adhesion molecule/CD3 bispecific antibody (BiTE), is highly active against primary chemotherapy-resistant ovarian cancer cell lines in vitro and fresh tumor cells ex vivo

(2014) Diana P. English et al.   CANCER

Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia

(2014) Max S. Topp et al.   JOURNAL OF CLINICAL ONCOLOGY

Expression of Epithelial Cell Adhesion Molecule in Paired Tumor Samples of Patients With Primary and Recurrent Serous Ovarian Cancer

(2013) Klaus Pietzner et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapy

(2012) S Bellone et al.   BRITISH JOURNAL OF CANCER

CD133+ Cancer Stem Cell-like Cells Derived from Uterine Carcinosarcoma (Malignant Mixed Müllerian Tumor)

(2011) Batsuren Choijamts et al.   STEM CELLS

High-grade, chemotherapy-resistant ovarian carcinomas overexpress epithelial cell adhesion molecule (EpCAM) and are highly sensitive to immunotherapy with MT201, a fully human monoclonal anti-EpCAM antibody

(2010) Christine E. Richter et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Overexpression of Epithelial Cell Adhesion Molecule in Primary, Metastatic, and Recurrent/Chemotherapy-Resistant Epithelial Ovarian Cancer

(2010) Stefania Bellone et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Ovarian and Uterine Carcinosarcomas

(2010) Gunjal Garg et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

The Emerging Role of EpCAM in Cancer and Stem Cell Signaling

(2009) M. Munz et al.   CANCER RESEARCH

Carcinosarcoma of the Ovary

(2009) Leigh A. Cantrell et al.   OBSTETRICAL & GYNECOLOGICAL SURVEY

Molecular genetic aberrations of ovarian and uterine carcinosarcomas—a CGH and FISH study

(2008) Alexander Schipf et al.   VIRCHOWS ARCHIV